Management Science
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


MANAGEMENT SCIENCE
Vol. 49, No. 5, May 2003, pp. 599-617
DOI: 10.1287/mnsc.49.5.599.15145
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huckman, R. S.
Right arrow Search for Related Content

The Utilization of Competing Technologies Within the Firm: Evidence from Cardiac Procedures

Robert S. Huckman

Harvard Business School, T17 Morgan Hall, Boston, Massachusetts 02163
rhuckman{at}hbs.edu

This paper examines the role of technological status in determining the rates at which competing techniques are used within a firm. Consistent with prior studies, technological status is measured on the basis of an actor's prior contributions to the body of knowledge concerning a given technique. The empirical analysis considers two treatments for coronary artery disease (CAD), each of which is associated with a distinct professional group within a hospital. These two groups are often characterized as engaging in a "turf war" for patients. After controlling for several factors that might explain technological choice—the clinical severity of patients, the relative quality of the two procedures at a given facility, firm-level financial performance, and other firm-level characteristics—I find that the technological status of the group associated with each technique affects the relative rate at which it is used within a given hospital. Moreover, this effect is strongest for patients at the margin between the two techniques. These results suggest that viewing the choice between competing innovations as a single, firm-level decision may not always capture the true dynamics underlying such a situation.

Key Words: Technological Choice; Competing Innovation; Technological Status; Intrafirm Groups
History: Received: November 5, 2001;


This article has been cited by other articles:


Home page
Med Care Res RevHome page
C. B. Rye and J. R. Kimberly
The Adoption of Innovations by Provider Organizations in Health Care
Med Care Res Rev, June 1, 2007; 64(3): 235 - 278.
[Abstract] [PDF]


Home page
Health Aff (Millwood)Home page
J. D. Ketcham, L. C. Baker, and D. MacIsaac
Physician Practice Size And Variations In Treatments And Outcomes: Evidence From Medicare Patients With AMI
Health Aff., January 1, 2007; 26(1): 195 - 205.
[Abstract] [Full Text] [PDF]


Home page
Management ScienceHome page
R. S. Huckman and G. P. Pisano
The Firm Specificity of Individual Performance: Evidence from Cardiac Surgery
Management Science, April 1, 2006; 52(4): 473 - 488.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by INFORMS.